Literature DB >> 20609988

Progress and barriers for the control of diarrhoeal disease.

Mathuram Santosham1, Aruna Chandran, Sean Fitzwater, Christa Fischer-Walker, Abdullah H Baqui, Robert Black.   

Abstract

Discovery of intestinal sodium-glucose transport was the basis for development of oral rehydration solution, and was hailed as potentially the most important medical advance of the 20th century. Before widespread use of oral rehydration solution, treatment for diarrhoea was restricted to intravenous fluid replacement, for which patients had to go to a health-care facility to access appropriate equipment. These facilities were usually neither available nor reasonable to use in the resource-poor settings most affected by diarrhoea. Use of oral rehydration solution has stagnated, despite being effective, inexpensive, and widely available. Thus, diarrhoea continues to be a leading cause of child death with consistent mortality rates during the past 5 years. New methods for prevention, management, and treatment of diarrhoea-including an improved oral rehydration formulation, zinc supplementation, and rotavirus vaccines-make now the time to revitalise efforts to reduce diarrhoea mortality worldwide. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609988     DOI: 10.1016/S0140-6736(10)60356-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

1.  Examining the use of oral rehydration salts and other oral rehydration therapy for childhood diarrhea in Kenya.

Authors:  Lauren S Blum; Prisca A Oria; Christine K Olson; Robert F Breiman; Pavani K Ram
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Prevalence of Rotaviruses Groups A and C in Egyptian Children and Aquatic Environment.

Authors:  Waled Morsy El-Senousy; Ahmed Mohammed El-Sayed Ragab; Eman Mohammed Abd El Hamed Handak
Journal:  Food Environ Virol       Date:  2015-02-11       Impact factor: 2.778

3.  Identification of Enteric Viruses in Foods from Mexico City.

Authors:  José Carlos Parada-Fabián; Patricia Juárez-García; Iván Natividad-Bonifacio; Carlos Vázquez-Salinas; Elsa Irma Quiñones-Ramírez
Journal:  Food Environ Virol       Date:  2016-05-24       Impact factor: 2.778

Review 4.  Development and Pathophysiology of Oral Rehydration Therapy for the Treatment for Diarrhea.

Authors:  Henry J Binder
Journal:  Dig Dis Sci       Date:  2020-02       Impact factor: 3.199

5.  Diarrhea Prevalence, Care, and Risk Factors Among Poor Children Under 5 Years of Age in Mesoamerica.

Authors:  Danny V Colombara; Bernardo Hernández; Claire R McNellan; Sima S Desai; Marielle C Gagnier; Annie Haakenstad; Casey Johanns; Erin B Palmisano; Diego Ríos-Zertuche; Alexandra Schaefer; Paola Zúñiga-Brenes; Nicholas Zyznieuski; Emma Iriarte; Ali H Mokdad
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

Review 6.  Secretory diarrhoea: mechanisms and emerging therapies.

Authors:  Jay R Thiagarajah; Mark Donowitz; Alan S Verkman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

7.  Defining the causes of diarrhea: novel approaches.

Authors:  Darwin J Operario; Eric Houpt
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

8.  Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1.

Authors:  Annika Skansberg; Molly Sauer; Marissa Tan; Mathuram Santosham; Mary Carol Jennings
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

9.  Use of oral rehydration therapy in the treatment of childhood diarrhoea in Douala, Cameroon.

Authors:  N E Essomba; D C Kedy Koum; D Adiogo; M I Ngwe; Y Coppieters
Journal:  Malawi Med J       Date:  2015-06       Impact factor: 0.875

Review 10.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.